XERS logo
XERS NASDAQ US

Xeris Biopharma Holdings, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jun 2018
$6.04
▲ +$0.00 (+0.00%)
Vol 1.3M
6
Quality Score
fail
Mkt Cap
$1.3B
ROE
-266.6%
Margin
-5.9%
D/E
4882.05
Beta
0.66
52W
$3–$10

Wall Street Consensus

13 analysts · Apr 2026
5
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
84.6%
Buy Rating

Price Chart

Similar Stocks

SEPN
Septerna Inc
$1.2B
EYPT
EyePoint Inc
$1.5B
COLL
Collegium Pharmaceutical Inc
P/E 25.0
$1.5B
AMPH
Amphastar Pharmaceuticals Inc
P/E 11.0
$1.2B
PCRX
Pacira Biosciences Inc
P/E 51.9
$1.1B
PHAT
Phathom Pharmaceuticals Inc
$1.2B
BIOA
BIOAGE Labs Inc
$474.4M
OMER
Omeros Corp
$1.2B

Earnings

Beat rate: 50.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.04 $0.06 +$0.02
Sep 2025 $0.00 $0.00 $0.00
Jun 2025 $-0.03 $-0.01 +$0.02
Mar 2025 $-0.05 $-0.06 $-0.01

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -266.6% -266.6% -266.6% -266.6% -266.6%
P/E (TTM) — — — — — —
Net Margin -2.7% -20.2% -13.0% -13.0% -5.9% -5.9%
Gross Margin 83.4% 82.2% 82.2% 82.2% 84.6% 84.6%
D/E Ratio — 4882.05 4882.05 4882.05 4882.05 4882.05
Current Ratio 1.95 1.72 1.95 1.95 1.93 1.93

Key Ratios

ROA (TTM)
-4.7%
P/S (TTM)
4.89
P/B
4.0
EPS (TTM)
$-0.10
CF/Share
$-0.36
Rev Growth 3Y
+60.0%
52W High
$10.08
52W Low
$3.14
$3.14 52-Week Range $10.08

How does XERS compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

XERS AARD ACB ACRS ADIL

XERS valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
4.9
▼ 1% below peers (5.0)
vs Peers
vs Industry
Fair value
P/B ratio
4.0
▲ 89% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

XERS profitability vs Pharmaceuticals peers

ROE
-266.6%
▼ 391% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-5.9%
▲ 88% above peers (-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
84.6%
▲ 24% above peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-4.7%
▲ 88% above peers (-37.4%)
vs Peers
vs Industry
Top tier

XERS financial health vs Pharmaceuticals peers

D/E ratio
4882.1
▲ 316916% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
1.9
▼ 43% below peers (3.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▼ 30% below peers (0.9)
vs Peers
vs Industry
More volatile

XERS fundamentals radar

XERS Peer median Industry

XERS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

XERS vs peers: key metrics

Latest News

No related news yet